Versus TB-500 / Thymosin beta-4 (43 AA, dose 2-10 mg): TB-500 acts mainly on the cytoskeleton (G-actin sequestration), cell migration and angiogenesis
Oxcarbazine (and, more specifically, its active metabolite MHD): Primary mechanism: blocks voltage-sensitive sodium channels, inhibiting repetitive neuronal firing
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Keleku-Lukwete N., Suzuki M., Otsuki A., Tsuchida K., Katayama S., Hayashi M., Naganuma E., Moriguchi T., Tanabe O., Engel J.D., et al
Priced at roughly 10,000/month
Tirzepatide delivered up to 22.5% weight loss in the SURMOUNT-1 trial, placing it between semaglutide and retatrutide in efficacy
If you qualify for medication, they contact you with treatment options